Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Melanoma 65Kidney Neoplasms 24Carcinoma, Renal Cell 23Neoplasm Metastasis 20Breast Neoplasms 16Skin Neoplasms 14Ovarian Neoplasms 11Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Uterine Cervical Neoplasms 6Neuroblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Leukemia 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lung Neoplasms 5Colonic Neoplasms 5Urogenital Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Sezary Syndrome 3Rectal Neoplasms 3Mycosis Fungoides 3

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 3Methotrexate 3Filgrastim 3Etoposide 3Cytarabine 3Busulfan 3sargramostim 2merphos 2Vorinostat 2Idarubicin 2Granulocyte-Macrophage Colony-Stimulating Factor 2Decitabine 2Cyclosporine 2tipifarnib 1palmitoyl-L-asparaginase 1entinostat 1bryostatin 1 1aldesleukin 1Vitamin E 1Transplantation 1Topotecan 1Thioguanine 1Thalidomide 1Tacrolimus 1Radiotherapy, Conformal 1Methylprednisolone 1Lenalidomide 1Isotretinoin 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia, Refractory × aldesleukin × Clear all
NCT00002798 2013-01-16

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
880 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡